Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Regeneron, Sanofi win stay of US order blocking cholesterol drug sales

      Regeneron, Sanofi win stay of US order blocking cholesterol drug sales

      supriya kashyap kashyap9 Feb 2017 11:24 AM IST
      A U.S. appeals court stayed an order that would have blocked Regeneron Pharmaceuticals Inc and Sanofi SA from selling their cholesterol drug,...
      FDA approves Amgen drug for secondary hyperparathyroidism

      FDA approves Amgen drug for secondary hyperparathyroidism

      supriya kashyap kashyap9 Feb 2017 11:23 AM IST
      The U.S. Food and Drug Administration has approved Amgen Inc's treatment for secondary hyperparathyroidism in adult patients with chronic kidney...
      Mylan agreed to pay $96.5 million in Provigil antitrust class action

      Mylan agreed to pay $96.5 million in Provigil antitrust class action

      supriya kashyap kashyap9 Feb 2017 11:22 AM IST
      Mylan NV has agreed to pay $96.5 million to settle claims by drug purchasers that it delayed launching a generic version of Cephalon Inc's narcolepsy...
      FDA seizes unlicensed medical devices worth over Rs 1 crore from GT Hospital

      FDA seizes unlicensed medical devices worth over Rs 1 crore from GT Hospital

      supriya kashyap kashyap8 Feb 2017 11:16 AM IST
      Mumbai : The Maharashtra Food and Drug Administration officials have seized unlicensed medical devices worth over Rs 1 crore, FDA commissioner...
      Online Sale of Medicines: Govt Committee Recommendations

      Online Sale of Medicines: Govt Committee Recommendations

      supriya kashyap kashyap8 Feb 2017 10:44 AM IST
      A Sub-Committee had been constituted by the Drugs Consultative Committee (DCC) to examine issues relating to online sale of drugs. The Sub-Committee...
      Several new drugs have been developed under AYUSH System: Shri Shripad Naik

      Several new drugs have been developed under AYUSH System: Shri Shripad Naik

      supriya kashyap kashyap8 Feb 2017 10:39 AM IST
      Central Council for Research in Ayurvedic Sciences (CCRAS) has developed anti-diabetic drug AYUSH-82 and AYUSH-SG for Rheumetoid Arthritis. Central...
      BioAsia 2017 kick starts with announcement of Rs.3,382 cr projects

      BioAsia 2017 kick starts with announcement of Rs.3,382 cr projects

      supriya kashyap kashyap8 Feb 2017 10:38 AM IST
      Hyderabad : BioAsia, Asia’s largest biotechnology and life-sciences forum and the annual flagship event of the Government of Telangana, kicked off at...
      Hilleman Laboratories awarded global patents for Oral Cholera Vaccine

      Hilleman Laboratories awarded global patents for Oral Cholera Vaccine

      supriya kashyap kashyap7 Feb 2017 11:50 AM IST
      New Delhi : Hilleman Laboratories, a joint-venture partnership between MSD and Wellcome Trust, has announced that it has been awarded a set of global...
      BoM signs corporate agency agreement with Cigna TTK Health

      BoM signs corporate agency agreement with Cigna TTK Health

      supriya kashyap kashyap7 Feb 2017 11:36 AM IST
      Mumbai : State-run Bank of Maharashtra has entered into a corporate agency agreement with Cigna TTK Health for distribution of the latter's products...
      Opioid addiction implant maker Braeburn Pharma pulls IPO

      Opioid addiction implant maker Braeburn Pharma pulls IPO

      supriya kashyap kashyap7 Feb 2017 11:15 AM IST
      Braeburn Pharmaceuticals Inc, the maker of the first long-acting implant to treat opioid addiction in the United States, said that it had decided not...
      Foundation stone laid for Biological E. vaccine unit in SEZ

      Foundation stone laid for Biological E. vaccine unit in SEZ

      supriya kashyap kashyap7 Feb 2017 11:00 AM IST
      Hyderabad : City-based vaccine manufacturer Biological E. Limited (BE) said it has laid the foundation stone for new facility in SEZ at Genome Valley...
      Thane manheld for impersonating as fda inspector

      Thane manheld for impersonating as fda inspector

      supriya kashyap kashyap6 Feb 2017 11:01 AM IST
      Thane : A 35-year-old man from Virar here, who posed as a Food and Drugs Administration (FDA) inspector and allegedly demanded bribe from a doctor,...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok